Studies have shown that CCR2+ TAMs, CAFs, and cancer-associated adipocytes serve as additional sources of CCL2; these findings demonstrate the non-canonical roles of CCL2 in fibrosis generation, mesenchymal–epithelial transition, paracrine-induced tumor invasion, and angiogenesis. The gene discussed is CCL2; the disease is cancer.